Symbol
Arvinas, Inc.
Full name of the company.
MEDICAL-BIOMED/GENETICS
Industry name
DRUGS
Major industry name
Medical
Sector name
$9.46
Current price of the stock
$1M
Trading volume of the stock
$690.6M
Market capitalization of the company
Small Cap
Category of market capitalization
1.27%
Long-term growth mean estimate
4.00
Mean analyst rating
90.27%
Potential price appreciation based on analyst price targets
3.45%
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
0.00
Total debt to total equity ratio
5.64
Current ratio
100.00%
Gross profit margin
-319.20%
Operating profit margin
-319.20%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-274.55%
Pretax profit margin
-273.21%
Net profit margin
-10.04%
Measures profitability relative to shareholders' equity
-10.04%
ROE excluding intangible assets
-6.73%
Measures profitability relative to total assets
-10.04%
Measures profitability relative to invested capital
0.02
Asset turnover ratio
-
Inventory turnover ratio
2.02
Receivables turnover ratio
44.60
Average number of days it takes to collect receivables
-9.37
Measures valuation relative to earnings
-2.88
P/E based on future earnings estimates
1.85
Measures valuation relative to sales
1.14
Measures valuation relative to book value
-0.97
Measures valuation relative to operating cash flow
-0.96
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC